Cargando…

Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination

Kawasaki disease (KD) and multisystem inflammatory syndrome (MIS) are rare conditions that occur predominately in children. Recent reports document KD and MIS in adult patients following infection with SARS-CoV-2. Rarely, MIS is observed following vaccination against SARS-CoV-2, mostly in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Showers, Christopher R, Maurer, Jaslyn M, Khakshour, Doreen, Shukla, Mohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255366/
https://www.ncbi.nlm.nih.gov/pubmed/35787506
http://dx.doi.org/10.1136/bcr-2022-249094
_version_ 1784740908891111424
author Showers, Christopher R
Maurer, Jaslyn M
Khakshour, Doreen
Shukla, Mohit
author_facet Showers, Christopher R
Maurer, Jaslyn M
Khakshour, Doreen
Shukla, Mohit
author_sort Showers, Christopher R
collection PubMed
description Kawasaki disease (KD) and multisystem inflammatory syndrome (MIS) are rare conditions that occur predominately in children. Recent reports document KD and MIS in adult patients following infection with SARS-CoV-2. Rarely, MIS is observed following vaccination against SARS-CoV-2, mostly in patients with prior SARS-CoV-2 infection. We report a case of KD in a man after a second SARS-CoV-2 vaccine dose, in absence of concurrent or prior SARS-CoV-2 infection. This patient also met criteria for probable MIS associated with vaccination. He tested negative for SARS-CoV-2 RNA via reverse transcriptase PCR, negative for SARS-CoV-2 nucleocapsid antibodies and demonstrated high levels SARS-CoV-2 spike protein antibodies, commonly used to assess vaccine response. Symptom improvement followed treatment with intravenous immunoglobulin, including desquamation of the hands and feet. As widespread vaccination against SARS-CoV-2 continues, increased vigilance and prompt intervention is necessary to limit the effects of postvaccination inflammatory syndromes.
format Online
Article
Text
id pubmed-9255366
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-92553662022-07-20 Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination Showers, Christopher R Maurer, Jaslyn M Khakshour, Doreen Shukla, Mohit BMJ Case Rep Case Reports: Adverse drug reactions and complications Kawasaki disease (KD) and multisystem inflammatory syndrome (MIS) are rare conditions that occur predominately in children. Recent reports document KD and MIS in adult patients following infection with SARS-CoV-2. Rarely, MIS is observed following vaccination against SARS-CoV-2, mostly in patients with prior SARS-CoV-2 infection. We report a case of KD in a man after a second SARS-CoV-2 vaccine dose, in absence of concurrent or prior SARS-CoV-2 infection. This patient also met criteria for probable MIS associated with vaccination. He tested negative for SARS-CoV-2 RNA via reverse transcriptase PCR, negative for SARS-CoV-2 nucleocapsid antibodies and demonstrated high levels SARS-CoV-2 spike protein antibodies, commonly used to assess vaccine response. Symptom improvement followed treatment with intravenous immunoglobulin, including desquamation of the hands and feet. As widespread vaccination against SARS-CoV-2 continues, increased vigilance and prompt intervention is necessary to limit the effects of postvaccination inflammatory syndromes. BMJ Publishing Group 2022-07-04 /pmc/articles/PMC9255366/ /pubmed/35787506 http://dx.doi.org/10.1136/bcr-2022-249094 Text en © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
spellingShingle Case Reports: Adverse drug reactions and complications
Showers, Christopher R
Maurer, Jaslyn M
Khakshour, Doreen
Shukla, Mohit
Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination
title Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination
title_full Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination
title_fullStr Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination
title_full_unstemmed Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination
title_short Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination
title_sort case of adult-onset kawasaki disease and multisystem inflammatory syndrome following sars-cov-2 vaccination
topic Case Reports: Adverse drug reactions and complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255366/
https://www.ncbi.nlm.nih.gov/pubmed/35787506
http://dx.doi.org/10.1136/bcr-2022-249094
work_keys_str_mv AT showerschristopherr caseofadultonsetkawasakidiseaseandmultisysteminflammatorysyndromefollowingsarscov2vaccination
AT maurerjaslynm caseofadultonsetkawasakidiseaseandmultisysteminflammatorysyndromefollowingsarscov2vaccination
AT khakshourdoreen caseofadultonsetkawasakidiseaseandmultisysteminflammatorysyndromefollowingsarscov2vaccination
AT shuklamohit caseofadultonsetkawasakidiseaseandmultisysteminflammatorysyndromefollowingsarscov2vaccination